Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study-Reference-Cited by-同舟云学术

Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study

Published:2022-09-21 Issue:2 Volume:36 Page:475-483
ISSN:1724-6059
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Fontana Francesco^ORCID,Cazzato Silvia,Giaroni Francesco,Bertolini Fabrizio,Alfano Gaetano,Mori Giacomo,Giovanella Silvia,Ligabue Giulia,Magistroni Riccardo,Cappelli Gianni,Donati Gabriele

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

https://link.springer.com/content/pdf/10.1007/s40620-022-01441-7.pdf

Reference20 articles.

1. Halimi J-M, Gatault P, Longuet H et al (2020) Major bleeding and risk of death after percutaneous native kidney biopsies. Clin J Am Soc Nephrol. https://doi.org/10.2215/cjn.14721219

2. Kumar V, Mitchell MD, Umscheid CA, Berns JS, Hogan JJ (2018) Risk of complications with use of aspirin during renal biopsy: a systematic review. Clin Nephrol 89(2):67–74. https://doi.org/10.5414/CN109274

3. Mackinnon B, Fraser E, Simpson K, Fox JG, Geddes C (2008) Is it necessary to stop antiplatelet agents before a native renal biopsy? Nephrol Dial Transplant 23(11):3566–3570. https://doi.org/10.1093/ndt/gfn282

4. Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B (2017) Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clin Kidney J. https://doi.org/10.1093/ckj/sfx012

5. Biondi-Zoccai GGL, Lotrionte M, Agostoni P et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27(22):2667–2674. https://doi.org/10.1093/eurheartj/ehl334